GPT Analysis

Empower Your Investments! Unleash the Potential with Smart Stock Analysis!

United States Hong Kong China Singapore Japan India
Sorting Arrows
Symbol
▲ ▼
Company Name Rating
▲ ▼
Recommendation
▲ ▼
Evaluation from GPT Action Time
▲ ▼
02342 COMBA 60 Positive Comba Telecom Systems Holdings Limited (2342.HK) is a communication equipment company based in Hong Kong. It operates in the technology sector and has 5,324 full-time employees. The company's stock price has been relatively stable, with a previous close of HKD 1.36 and a current price of HKD 1.33. The stock has a 52-week range of HKD 1.05 to HKD 1.72.

2023-07-20 08:08:53
02350 MTT GROUP 60 Positive MTT Group Holdings Limited (2350.HK) is a technology company based in Hong Kong. The company operates in the information technology services sector and has a market capitalization of HKD 575 million. MTT Group has a trailing P/E ratio of 9.2, indicating that the stock is relatively undervalued compared to its earnings. The company has a strong balance sheet with a current ratio of 2.109 and a quick ratio of 1.773, indicating its ability to meet short-term obligations. MTT Group has a return on equity of 30.573%, indicating its efficiency in generating profits from shareholders' investments. However, the company has negative earnings and revenue growth, which raises concerns about its future prospects. Overall, MTT Group is a relatively small technology company with potential for growth, but investors should carefully consider the risks associated with its negative growth rates.

2023-10-02 17:43:11
02552 HUA MEDICINE-B 60 Negative Hua Medicine (Shanghai) Ltd. (2552.HK) is operating in the drug manufacturing industry, specifically focusing on specialty and generic drugs. The company has 144 employees and is based in Beijing, China. The stock's previous close was $1.86, and it opened at $1.93 today. The day's low was $1.91, and the high was $2.02. The 52-week range is $1.48 to $5.02. The company has a market capitalization of $1.86 billion. The price-to-sales ratio is 105.84, which indicates a relatively high valuation compared to its revenue. The average daily trading volume for the past 10 days is 1,748,600 shares.

Despite the stock's recent decline of 49.46%, the S&P 500 index has increased by 14.13% during the same period. The company has negative net income of $203.5 million and trailing earnings per share of -$0.27. The forward price-to-earnings ratio is infinity due to negative earnings. However, it's important to note that analysts have a buy recommendation for this stock with a target price range of $3.51 to $7.57. The company has a good cash position with $490.63 million in cash and a total debt of $97.58 million.

Considering the negative financial performance and high valuation, as an AI, I would rate this stock with a score of 60, indicating below-average prospects. However, analysts' buy recommendation and the positive cash position suggest potential opportunities. It's important to perform a thorough analysis of the company's financial statements, market trends, and future growth prospects before making an investment decision.

2023-07-10 06:34:44
06118 AUSTAR 60 Positive Austar Lifesciences Limited (6118.HK) is a medical devices company based in China. The company operates in the healthcare sector and has a market capitalization of HKD 1,537,746,048. Austar Lifesciences has a trailing P/E ratio of 15.79, indicating that the stock is relatively undervalued compared to its industry peers. The company has shown a negative earnings growth of -27.3% and a revenue growth of -3% in the most recent quarter. However, it has a positive return on equity of 8.1% and a return on assets of 2.5%. Austar Lifesciences has a strong balance sheet with a current ratio of 1.32 and a quick ratio of 0.86, indicating its ability to meet short-term obligations. The stock has a 52-week high of HKD 3.18 and a 52-week low of HKD 1.27. Considering the company's financial indicators and performance, it is recommended to conduct further research and analysis before making an investment decision.

2023-08-19 18:56:48
06628 TRANSCENTA-B 60 Positive Transcenta Holding Limited (6628.HK) is a biotechnology company based in China. The company operates in the healthcare sector and specializes in the development of biopharmaceutical products. With a market capitalization of HKD 1,726,876,032, Transcenta Holding has a relatively small market presence. The stock has a beta of -0.092406, indicating that it is less volatile than the overall market. The company's financial indicators show negative net income and negative trailing EPS, suggesting that it is currently not profitable. However, Transcenta Holding has shown strong revenue growth of 65.8% and has a positive recommendation from analysts. The target mean price is HKD 8.57, indicating potential upside. Considering the positive revenue growth and analyst recommendation, it may be worth considering Transcenta Holding as a long-term investment option.

2023-10-08 15:33:06
06699 ANGELALIGN 60 Negative Angelalign Technology Inc. (6699.HK) operates in the Medical Instruments & Supplies industry within the Healthcare sector. The company has a market capitalization of HKD 11,058,625,536, with 2144 full-time employees. Angelalign Technology Inc. manufactures and distributes orthodontic products. The company's trailing P/E ratio is 51.71, and its forward P/E ratio is 30.30, indicating a relatively high valuation. The stock's 52-week range is HKD 61.20 to HKD 158.30. However, the stock has experienced a significant decline of 52.17% in the past year. The company's financial indicators show a positive profit margin of 16.84% and a return on equity of 6.16%. With no dividend payouts and limited earnings growth, investors should carefully consider the risks before investing in Angelalign Technology Inc.

2023-07-09 14:54:36
02350 MTT GROUP 60 Positive MTT Group Holdings Limited (2350.HK) is a technology company based in Hong Kong. The company operates in the information technology services sector and has a market capitalization of HKD 575 million. MTT Group has a trailing P/E ratio of 9.2, indicating that the stock is relatively undervalued compared to its earnings. The company has a strong balance sheet with a current ratio of 2.109 and a quick ratio of 1.773, indicating its ability to meet short-term obligations. MTT Group has a return on equity of 30.573%, indicating its efficiency in generating profits from shareholders' investments. However, the company has negative earnings and revenue growth, which raises concerns about its future prospects. Overall, MTT Group is a relatively small technology company with potential for growth, but investors should carefully consider the risks associated with its negative growth rates.

2023-10-02 17:43:11
06628 TRANSCENTA-B 60 Positive Transcenta Holding Limited (6628.HK) is a biotechnology company based in China. The company operates in the healthcare sector and specializes in the development of biopharmaceutical products. With a market capitalization of HKD 1,726,876,032, Transcenta Holding has a relatively small market presence. The stock has a beta of -0.092406, indicating that it is less volatile than the overall market. The company's financial indicators show negative net income and negative trailing EPS, suggesting that it is currently not profitable. However, Transcenta Holding has shown strong revenue growth of 65.8% and has a positive recommendation from analysts. The target mean price is HKD 8.57, indicating potential upside. Considering the positive revenue growth and analyst recommendation, it may be worth considering Transcenta Holding as a long-term investment option.

2023-10-08 15:33:06
06608 BAIRONG-W 60 Negative The stock 6608.HK is trading at a low price of HKD 10.36 with a market cap of HKD 5,317,880,980. The yearHigh of HKD 14.80 and yearLow of HKD 8.09 indicate price volatility. The stock's previousClose price was HKD 11.06, suggesting a downward movement. The stock's yearChange of -0.09 indicates a negative performance compared to the previous year. The fiftyDayAverage and the twoHundredDayAverage are 12.28 and 11.12, respectively, suggesting a slightly bearish trend. The tenDayAverageVolume and the threeMonthAverageVolume are 2,614,476 and 1,699,516, respectively. The stock has a healthy trading volume.

Considering these factors, the sentiment for investing in 6608.HK is Negative. The stock has witnessed a decline in its price and a negative yearChange. However, individual investment goals and risk appetites should be taken into account. The rating for this stock is 60. It is neither very good nor very bad.

2024-04-03 14:10:50
00270 GUANGDONG INV 55 Negative Guangdong Investment Limited (0270.HK) is a regulated water utilities company based in Hong Kong. With over 10,000 full-time employees, the company operates in the utilities sector. Despite a relatively low beta of 0.563, indicating lower volatility compared to the market, the stock has displayed a negative 52-week change of -19.16%. The trailing P/E ratio of 8.63 suggests that the stock may be undervalued. Additionally, the dividend yield of 9.19% and a five-year average yield of 5.22% make it attractive for income-oriented investors. However, the company's negative earnings growth rate of -13.6% raises concerns about its future profitability. Considering the overall information, the sentiment towards Guangdong Investment Limited is negative, and it is worth analyzing the stock further before making an investment decision.

2023-07-20 02:03:16
00914 CONCH CEMENT 55 Negative Anhui Conch Cement Company Limited (0914.HK) is a leading player in the building materials industry in China. The company has a strong market presence with a large number of employees and a solid governance rating. It has consistently paid dividends, with a dividend yield of 8.31% and a payout ratio of 94.49%. However, the stock has experienced a significant decline in the past year, with a 52-week change of -40.72%. The company's financial performance has also been mixed, with negative earnings and revenue growth. The stock has a trailing P/E ratio of 7.32 and a forward P/E ratio of 9.08. Despite the low valuation, the stock carries some risks, including a relatively high debt-to-equity ratio of 11.25. Overall, the stock has potential for long-term value, but investors should carefully assess the risks involved.

2023-07-20 08:11:59
01970 IMAX CHINA 55 Negative IMAX China Holding, Inc. (1970.HK) is a leading entertainment company in China. The company operates in the communication services sector and specializes in providing immersive entertainment experiences through its advanced film projection technology. With a solid market cap of HKD 3,087,603,200 and a strong presence in the industry, IMAX China has positioned itself as a key player in the Chinese entertainment market.

Financially, IMAX China has shown consistent growth in revenue, with a trailing twelve-month revenue of HKD 73,330,000. However, its net income has been impacted recently, showing a decline in the previous quarter. The company pays dividends, with a dividend rate of 0.12% and a dividend yield of 0.0182, which is relatively low compared to the industry average.

Considering the current performance, it is crucial to be cautious before investing. IMAX China has a trailing P/E ratio of 39.65, indicating that the stock may be overvalued. Additionally, the company's stock price has been volatile over the past year, with a 52-week low of HKD 4.00 and a 52-week high of HKD 12.00.

The overall sentiment towards investing in IMAX China (1970.HK) is negative due to the declining net income and the recent volatility in its stock price. Given these factors, it is advisable to conduct further research and analysis before making any investment decisions.

2023-07-11 05:16:38
00004 WHARF HOLDINGS 50 Negative Wharf (Holdings) Limited (0004.HK) is a real estate development company based in Hong Kong, with over 6,200 full-time employees. The company's financial indicators are mixed. On one hand, its P/E ratio is relatively low at 9.45, indicating that it may be undervalued. On the other hand, it has negative profit margins of -9.44% and a negative trailing EPS of -0.56. Its revenue growth is also negative at -0.019. However, the company has a good dividend history with a relatively high yield of 2.24% and a strong five-year average dividend yield of 2.75%. In addition, it has a low price-to-book ratio of 0.35, indicating it may be undervalued. Overall, there are mixed signals and further research should be conducted before investing.

2023-06-24 08:56:50
00142 FIRST PACIFIC 50 Neutral First Pacific Company Limited, a packaged foods company based in Hong Kong, has shown mixed financial indicators across various measures. Although the company has a relatively low P/E ratio indicating a potentially undervalued stock, it’s important to note that their return on equity is only slightly above industry standards. At the same time, the company’s profit margins are higher than the industry average, which is an encouraging sign for investors. Additionally, their revenue has grown over the past year, which could indicate future growth potential.
However, the company has seen negative earnings growth over the past year, which may be a concern for investors. Additionally, the company has a high debt-to-equity ratio, which may increase their financial risk and put them in a more vulnerable position during economic downturns.
Overall, the decision whether to invest in First Pacific Company Limited should depend on the investor's risk tolerance and investment objectives. The company’s mixed financial indicators may indicate some potential for growth, but their negative earnings growth and high debt-to-equity ratio may also increase financial risk.

2023-06-26 16:20:41
00241 ALI HEALTH 50 Negative Alibaba Health Information Technology Limited (0241.HK) is a healthcare company operating in the pharmaceutical retail sector. The company has a market capitalization of HKD 66,042,503,168 and employs 1,560 full-time employees. It has a trailing P/E ratio of 97.6 and a forward P/E ratio of 54.22, indicating that the stock may be overvalued. The stock has a beta of 1.24, suggesting that it is slightly more volatile than the overall market. The company's financial indicators show a profit margin of 1.99%, return on assets of -0.16%, and return on equity of 3.66%. The stock has a 52-week range of HKD 3.0 to HKD 10.14. The average daily volume over the past 10 days is 30,991,301 shares. Based on these factors, the stock may not be a suitable investment option at this time.

2023-10-02 17:12:21
00659 NWS HOLDINGS 50 Negative NWS Holdings Limited (0659.HK) operates in the Engineering & Construction sector within the Industrials industry. It has a dividend yield of 0.075%, and the trailing PE ratio is 27.81. The forward PE ratio is 13.28, and the PEG ratio is -2.00. The company's profit margins are 5.41%, and its return on equity is 3.24%. 0659.HK has a market capitalization of HKD 34.80 billion and a beta of 0.59. Based on these indicators, the stock seems to be trading at high valuations, which may not be justified by its financial metrics.

2023-06-27 15:21:36
00754 HOPSON DEV HOLD 50 Negative Hopson Development Holdings Limited (0754.HK) is a real estate development company based in Hong Kong. The company has a strong market presence with a large number of full-time employees and a significant market capitalization. However, the stock has been underperforming in the past year, with a negative 52-week change of -6.78%. The company's financial indicators show mixed results, with a low trailing PE ratio of 2.49 and a high debt-to-equity ratio of 95.18. The company's profit margins are relatively healthy at 21.52%, but the earnings growth rate is negative at -38.9%. The stock does not pay dividends. Overall, the stock has a moderate risk profile and may not be suitable for conservative investors. It is recommended to closely monitor the company's financial performance and market conditions before making an investment decision.

2023-10-12 04:53:42
01057 ZHEJIANG SHIBAO 50 Negative Zhejiang Shibao Company Limited (1057.HK) is a Chinese auto parts company operating in the consumer cyclical sector. The company has a market capitalization of HKD 11,192,145,920 and operates with 1,697 full-time employees. With a trailing P/E ratio of 70.25, the stock appears to be overvalued compared to its industry peers. The stock has shown a positive revenue growth of 32.4% and has a gross margin of 19.38%. However, the company's profit margins are relatively low at 1.97%. Zhejiang Shibao has a debt-to-equity ratio of 14.966, indicating a relatively high level of debt. The stock has a 52-week range of HKD 1.26 to HKD 3.65. Considering the high valuation and debt levels, it is recommended to approach this investment with caution.

2023-08-20 07:49:08
01833 PA GOODDOCTOR 50 Negative Ping An Healthcare and Technology Company Limited (1833.HK) is a healthcare information services company based in China. The company operates in the healthcare sector and has a market capitalization of HKD 20,586,102,784. With a beta of 0.75783, the stock is less volatile compared to the overall market. The company's financial indicators show a negative profit margin of -0.07021 and a negative trailing EPS of -0.39. The company has a high overall risk rating of 9, indicating potential risks associated with its operations. The stock has a 52-week high of HKD 34.2 and a 52-week low of HKD 13.5. Based on the financial indicators and risk profile, it is recommended to approach this investment with caution.

2023-10-12 05:06:10
02356 DAHSING BANKING 50 Negative Dah Sing Banking Group Limited (2356.HK) is a regional bank based in Hong Kong. The company operates in the Financial Services sector and has a market capitalization of HKD 7.9 billion. With a trailing P/E ratio of 5.24 and forward P/E ratio of 5.1, the stock appears to be undervalued. Additionally, the company offers a dividend yield of 6.85%, which is higher than the industry average. However, it is important to note that the company has a high overall risk rating of 10, indicating potential volatility. The financial indicators also show negative earnings and revenue growth. In summary, although the stock seems undervalued and offers a decent dividend yield, the high overall risk and negative growth metrics make it a risky investment.

2023-07-21 12:32:29